Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
- 16 December 2019
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 74 (25), 3099-3108
- https://doi.org/10.1016/j.jacc.2019.10.038
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung CancerNew England Journal of Medicine, 2015
- Cancer immunotherapy: harnessing the immune system to battle cancerJCI Insight, 2015
- Troponin and Cardiac Events in Stable Ischemic Heart Disease and DiabetesNew England Journal of Medicine, 2015
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2014
- Current concepts in the diagnosis and management of cytokine release syndromeBlood, 2014
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 2014
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Cardiac Troponin and Outcome in Acute Heart FailureNew England Journal of Medicine, 2008
- Cardiogenic ShockCell Metabolism, 2008
- The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2004